link here

ART-TG will present on Sept 11 in S04 Advances in manufacturing. PROGRAMME HERE Abstract submission link here.

https://www.frontiersin.org/articles/10.3389/fimmu.2025.1567582 T2Evolve aims to accelerate the development of T cell-based gene...

Plus de 60 Conférences, tables rondes, discussions. PROGRAMME

We hope for many successful projects with our collaborators and thank you for your support.

More than 220 persons attended the event and we are grateful to the speakers, participants and sponsors for the quality of the exchanges...

This one day event will provide the latest news in cell and gene therapy. Free registration !

A keynote presentation by A. Galy entitled "Immune system friend or foe in gene therapy", was presented today at the ESGCT 2024 Spring...

Massy, 3-4 Avril 2024 #INSERM #Genopole #ART-TG

Click here Linkedin to follow the activities, news and job opportunities at ART-TG

Ecoutez Anne Galy sur France Culture. Science Chrono, émission d’Antoine Beauchamp, diffusée le Samedi 8 Octobre 2023.

POST-DOCTORAL POSITION NEW - APPLY ! HEAD OF BIOPRODUCTION https://www.art-tg.com/jobs

https://www.genopole.fr/temps-forts/agenda/symposium-cart-cells-art-tg/ #inserm #ART-TG #genopole

Galy and co-authors have recently published in Human Gene Therapy, a review of recent strategies using gene therapy and genetic vaccines...

Evaluation of diversity indices to estimate clonal dominance in gene therapy studies by Guillaume Corre and Anne Galy. Molecular Therapy...

Mai 19, 2023 ART-TG / Inserm is proud to be part of the gene therapy biocluster GENOTHER, one of the 5 bioclusters announced by the...